Company intelligence / Profile preview

Pragmatech AI Solutions

Ownership: Private
Development stage: Other

Overview

Pragmatech AI Solutions develops artificial intelligence-based software products focused on healthcare applications. Their main offerings include clinical decision support systems that assist clinicians in diagnosis, treatment selection—particularly for infectious diseases—and optimizing antibiotic prescriptions. The company leverages omics data, advanced mathematical modeling, machine learning, and natural language processing to deliver personalized medicine insights. Their flagship product "IAST" aims to improve empirical antibiotic therapy decisions before definitive lab results are available. Products undergo a three-stage validation process including mathematical review, specialist benchmarking, and clinical trials.

Therapeutic areas: Infectious DiseasesOther
Modalities: Software
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Pragmatech AI Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pragmatech AI Solutions.

Explore the full profile